These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19666117)

  • 1. Insulin: a new era for an old hormone.
    Sabetsky V; Ekblom J
    Pharmacol Res; 2010 Jan; 61(1):1-4. PubMed ID: 19666117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin therapy in patients with type 2 diabetes].
    Siegmund T; Schumm-Draeger PM
    MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin therapy in type 2 diabetes].
    Hummel M
    MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Role of Insulin Therapy In Diabetes.
    Rodbard HW
    J Fam Pract; 2016 Oct; 65(10 Suppl):S3-S7. PubMed ID: 27846336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the last be first? Questions and dilemmas regarding early short-term insulin treatment in Type 2 Diabetes Mellitus.
    Koufakis T; Karras SN; Zebekakis P; Ajjan R; Kotsa K
    Expert Opin Biol Ther; 2018 Nov; 18(11):1113-1121. PubMed ID: 30244600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensified therapy with insulin analogs in type 2 diabetes: normalizing metabolism and maintaining body weight?].
    Jungmann E; Helling T; Jungmann G; Mertens C; Snelting U
    MMW Fortschr Med; 2000 Oct; 142(43):48. PubMed ID: 11098614
    [No Abstract]   [Full Text] [Related]  

  • 9. [When tablets are no longer enough. Which insulin for type 2 diabetic patients?].
    MMW Fortschr Med; 2002 Sep; 144(38):58. PubMed ID: 12395711
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes.
    Giugliano D; Esposito K
    Diabet Med; 2011 Feb; 28(2):247. PubMed ID: 21219438
    [No Abstract]   [Full Text] [Related]  

  • 11. [HbA1c is too high despite tablets. With single injections toward better blood glucose values].
    MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347083
    [No Abstract]   [Full Text] [Related]  

  • 12. Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in type 2 diabetes.
    Bolli GB; Lucidi P; Porcellati F; Fanelli CG
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S220-4. PubMed ID: 21525459
    [No Abstract]   [Full Text] [Related]  

  • 13. As U-500 Insulin Safety Concerns Mount, It's Time to Rethink Safe Use of Strengths Above U-100.
    Shastay A
    Home Healthc Now; 2015 Oct; 33(9):501-2. PubMed ID: 26418111
    [No Abstract]   [Full Text] [Related]  

  • 14. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of insulin detemir in overweight type 2 diabetes management.
    Demssie YN; Younis N; Soran H
    Vasc Health Risk Manag; 2009; 5(3):553-60. PubMed ID: 19590589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
    Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
    Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summaries for patients. A comparison of three insulin regimens (morning glargine, bedtime glargine, or bedtime neutral protamine Hagedorn) in addition to a pill for treating type 2 diabetes.
    Ann Intern Med; 2003 Jun; 138(12):I33. PubMed ID: 12809480
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus.
    Lalić NM; Micić D; Antić S; Bajović L; Pantelinac P; Jotić A; Kendereski A; Dimić D; Djukić A; Mitrović M; Vujasin M
    Expert Opin Pharmacother; 2007 Dec; 8(17):2895-901. PubMed ID: 18001251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.
    Lankisch MR; Del Prato S; Dain MP; Mullins P; Owens DR
    Prim Care Diabetes; 2016 Feb; 10(1):51-9. PubMed ID: 26150328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.